Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    "Burning mouth syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Burning mouth syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
Condition: Burning Mouth Syndrome
Intervention: Dietary Supplement: melatonin
2 Completed The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study
Condition: Burning Mouth Syndrome
Interventions: Drug: Uréia;   Drug: Placebo
3 Completed Neurogenic Mechanisms in Burning Mouth Syndrome
Condition: Burning Mouth Syndrome
Interventions: Other: Capsaicin oral gel 0.025%;   Other: Capsaicin oral gel 0.01%
4 Not yet recruiting Botulinum Toxin in Burning Mouth Syndrome
Condition: Burning Mouth Syndrome
Interventions: Drug: Botulinum Neurotoxin Type A;   Other: Normal saline
5 Completed A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome
Condition: Burning Mouth Syndrome
Intervention:
6 Completed Acupuncture Versus Clonazepam in Burning Mouth Syndrome
Condition: Burning Mouth Syndrome
Interventions: Drug: Clonazepam;   Other: acupuncture
7 Enrolling by invitation Study Evaluating the Laser Diode Effect Burning Mouth Syndrome
Condition: Burning Mouth Syndrome
Intervention: Radiation: laser diode
8 Not yet recruiting Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
Condition: Burning Mouth Syndrome
Interventions: Drug: Clonazepam mixed with Mucolox®;   Drug: Mucolox® alone;   Drug: Clonazepam
9 Completed Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)
Condition: Burning Mouth Syndrome
Intervention: Biological: sample
10 Recruiting HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Condition: Atrophic Glossitis, Burning Mouth Syndrome
Intervention: Dietary Supplement: Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
11 Unknown  Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome
Condition: Burning Mouth Syndrome
Interventions: Dietary Supplement: Gluten Free Diet;   Dietary Supplement: Normal Diet
12 Terminated
Has Results
Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain
Conditions: Temporomandibular Joint Dysfunction Syndrome;   Burning Mouth Syndrome
Interventions: Drug: nalbuphine plus naloxone;   Drug: nalbuphine plus placebo
13 Completed Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders
Conditions: Fibromyalgia;   Irritable Bowel Syndrome;   Burning Mouth Syndrome
Intervention: Device: Repetitive transcranial magnetic stimulation
14 Completed Thalidomide to Treat Oral Lesions in HIV-Infected Patients
Conditions: Acquired Immunodeficiency Syndrome;   Burning Mouth Syndrome;   HIV Infection
Intervention: Drug: Thalidomide
15 Unknown  Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
Conditions: Burning Mouth Syndrome;   Taste Disorder;   Orofacial Pain
Intervention:
16 Completed Alpha Lipoic Acid for Burning Mouth
Condition: Burning Sore Mouth
Intervention:
17 Terminated Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Chronic Oral Pain
Condition: Chronic Pain
Interventions: Drug: Bupivacaine;   Drug: Placebo
18 Completed Evaluation and Treatment of Oral Soft Tissue Diseases
Conditions: Aphthous Stomatitis;   Burning Mouth Syndrome;   Lichen Planus;   Mouth Disease;   Temporomandibular Joint Disorder
Interventions: Procedure: Electrocardiogram;   Procedure: Biopsies;   Procedure: Diagnostic imaging
19 Recruiting Assessment of Peripheral GABA Receptors for Local Pain Relief
Condition: Pain
Interventions: Drug: GABA oral solution;   Drug: Intramuscular GABA;   Drug: Pain modulation

Study has passed its completion date and status has not been verified in more than two years.